Genetic and Rare Diseases Information Center (GARD)


Other names people use for this condition
  • Angiokeratoma, diffuse
  • Anderson-Fabry disease
  • Hereditary dystopic lipidosis
  • Alpha-galactosidase A deficiency
  • GLA deficiency
  • Angiokeratoma corporis diffusum
  • Ceramide trihexosidase deficiency



Fabry disease
Please note that the links contained on this search results page may take you to sites outside of the NIH. (See Disclaimer under Site Policies for details.)


Fabry disease is an inherited disorder that is caused by the buildup of a specific type of fat called globotriasylceramide.  The buildup occurs because individuals with Fabry disease have a mutation in the GLA gene.  The GLA gene provides instructions for the making of an enzyme called alpha-galactosidase A.  The mutation in the GLA gene changes the structure and function of alpha-galactosidase A, preventing the breakdown of globotriasylceramide.  The buildup leads to the damage of the cells lining blood vessels and cells in the kidneys, heart, and nervous system.  The damage caused by the buildup leads to the various symptoms of Fabry disease. [1]

References
  1. Fabry disease. Genetics Home Reference (GHR) Web site. March 2007 Available at: http://ghr.nlm.nih.gov/condition=fabrydisease. Accessed April 14, 2009.

Questions & Answers (Found 1 Question)
A list of questions from the public on rare and/or genetic diseases that have been answered by the Genetic and Rare Disease Information Center. Click on each question to find the answer.


For more information about Fabry disease click on the boxes below:
More Detailed Information NLM Gateway Medical Products Services Support Groups Clinical Trials & Research



Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.